Published in Cancer Weekly, July 26th, 2005
The investors in this round are Inventages venture capital investments, Inc., and Seroba Bioventures of Ireland. Commensurate with this funding, Erich Sieber of Inventages and Alan O'Connell of Seroba join the board of directors for TriMed Research. The series A funding will be used for the development of a family of proteins designated as MAA, and the initiation of clinical trials.
TriMed Research is a joint...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.